Literature DB >> 11742835

Decreased hematopoiesis in bone marrow of mice with congestive heart failure.

Per Ole Iversen1, Per Reidar Woldbaek, Theis Tønnessen, Geir Christensen.   

Abstract

Patients with heart failure are predisposed to infections and anemia, possibly due to reduced hematopoiesis. The proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) is increased in heart failure, and it inhibits normal hematopoiesis, partly due to apoptosis through the effector molecule Fas. We examined bone marrow progenitor cells of mice with heart failure induced by acute myocardial infarction. The fraction of progenitor cells in mice with heart failure was only approximately 40% of control. Measured with in vitro clonal assays, the proliferative capacity of the progenitor cells in mice with heart failure was reduced to approximately 50% of control. Flow cytometry with specific markers revealed a threefold increase in apoptosis among progenitor cells from mice with heart failure. In these mice, TNF-alpha/Fas expression was increased in bone marrow natural killer (NK) and T cells, and these lymphocytes showed increased cytolytic activity in vitro against progenitor cells. We conclude that the TNF-alpha/Fas pathway in lymphocytes is activated in the bone marrow during heart failure, which may play a pathogenic role in the observed decrease in hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11742835     DOI: 10.1152/ajpregu.2002.282.1.R166

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  24 in total

1.  Anaemia and heart failure.

Authors:  A J S Coats
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 2.  Systemic inflammation in heart failure--the whys and wherefores.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Oie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

3.  Treatment of anemia in the patient with heart failure.

Authors:  Rebecca P Streeter; Donna Mancini
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

Review 4.  Cardiorenal disease: a clinical intersection.

Authors:  Vikram Kalra; Sandeep Mahajan; Sanjay Kumar Agarwal; Suresh Chander Tiwari
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Association between left ventricular dysfunction, anemia, and chronic renal failure. Analysis of the Heart Failure Prevalence and Predictors in Turkey (HAPPY) cohort.

Authors:  A Kepez; B Mutlu; M Degertekin; C Erol
Journal:  Herz       Date:  2013-11-13       Impact factor: 1.443

6.  Managing anemia in patients with chronic heart failure: what do we know?

Authors:  Ankur Sandhu; Sandeep Soman; Michael Hudson; Anatole Besarab
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

7.  Loss of SIMPL compromises TNF-alpha-dependent survival of hematopoietic progenitors.

Authors:  Eric A Benson; Mark G Goebl; Feng-Chun Yang; Reuben Kapur; Jeanette McClintick; Sonal Sanghani; D Wade Clapp; Maureen A Harrington
Journal:  Exp Hematol       Date:  2009-11-23       Impact factor: 3.084

8.  Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions.

Authors:  Dmitry Abramov; Rose S Cohen; Stuart D Katz; Donna Mancini; Mathew S Maurer
Journal:  Am J Cardiol       Date:  2008-07-31       Impact factor: 2.778

9.  Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.

Authors:  David H Smith; Micah L Thorp; Jerry H Gurwitz; David D McManus; Robert J Goldberg; Larry A Allen; Grace Hsu; Sue Hee Sung; David J Magid; Alan S Go
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-05-17

Review 10.  Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.

Authors:  B Daan Westenbrink; Adriaan A Voors; Willem-Peter T Ruifrok; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.